机译:DNA旋转酶B(GyrB)和拓扑异构酶IV(PARE)的吡咯哒嘧啶抑制剂。 第一部分:结构引导和优化双靶向剂,具有效率,广谱酶活性
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Lawrence Livermore National Laboratory Physical and Life Sciences Directorate Livermore CA 94550;
Lawrence Livermore National Laboratory Physical and Life Sciences Directorate Livermore CA 94550;
Lawrence Livermore National Laboratory Physical and Life Sciences Directorate Livermore CA 94550;
Advanced Light Source Beamline 4.2.2 1 Cyclotron Rd. Berkeley CA 94720 United States;
Trius Therapeutics 6310 Nancy Ridge Dr. San Diego CA 92121 United States;
Bacterial topoisomerases; GyrB; Inhibitor; ParE; Pyrrolopyrimidine;
机译:DNA旋转酶B(GyrB)和拓扑异构酶IV(PARE)的吡咯哒嘧啶抑制剂。 第一部分:结构引导和优化双靶向剂,具有效率,广谱酶活性
机译:DNA旋转酶B(GyrB)和Topoisomerase IV(PARE)的吡咯哒嘧啶抑制剂,第II部分:具有广谱的抑制剂的发育,革兰氏阴性抗菌活性
机译:DNA旋转酶B(GyrB)和Topoisomerase IV(PARE)的吡咯哒嘧啶抑制剂,第II部分:具有广谱的抑制剂的发育,革兰氏阴性抗菌活性
机译:新型双MDM2和MDMX靶向吻合α-螺旋肽的设计,合成,生物物理和结构 - 活性特性:ATSP-7041在体外表现出效率和体内人类癌症的模型
机译:P27作为癌症治疗的分子靶标:发现p27蛋白水解和结构活性关系的小分子抑制剂以及组蛋白脱乙酰基酶的有效抑制剂largazole的机理研究。
机译:三环GyrB / ParE(TriBE)抑制剂:一类新型的广谱双靶向抗菌剂
机译:DNA旋转酶和拓扑异构酶IV抑制剂的发现与优化氟代喹啉龙抗革兰氏阳性细菌有效活性